(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

VÍRUS VACCINIA RECOMBINANTE

ArquivadaInvention PatentPCT · IB2021056192

Application data

Number

112023000650

Type

Invention Patent

Filing

07/09/2021

Publication

01/31/2023

PCT

IB2021056192

Progress at the INPI

  1. Filing07/09/21
  2. Publication01/31/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 07/09/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/01/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

PFIZER INC.

US

See this company's full portfolio

Inventors

C. L. (pessoa física)

US

J. P. (pessoa física)

US

J. M. (pessoa física)

US

J. B. (pessoa física)

US

M. E. (pessoa física)

US

Technical data

Priority claims

US

63/051,628 · 07/14/2020

US

63/051,890 · 07/14/2020

Abstract

VÍRUS VACCINIA RECOMBINANTE. A presente invenção refere-se a variantes de IL-2 humana, vírus oncolíticos recombinantes compreendendo a variante de IL-2, composições compreendendo a variante de IL-2 ou vírus oncolítico recombinante, e uso das variantes de IL-2, vírus oncolítico recombinante, ou composições para tratamento de câncer em um indivíduo.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

10/01/2024

RPI 2804

Arquivamento - Art. 33 da LPI

#11.1

07/16/2024

RPI 2793

Alteração de sede deferida

#25.7

08/08/2023

RPI 2744

Notificação de entrada na fase nacional - PCT

#1.3

01/31/2023

RPI 2717

Alteração de dados cadastrais

#1.1

01/24/2023

RPI 2716

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.